Deutsche Bank has today announced it has been appointed by Euroclear Bank SA/NV as Cash Settlement and Foreign Exchange Bank (under Euroclear direct link) with the Korea Securities Depository (KSD). The mandate is to support South Korean government bond activity for Korea Treasury Bonds (KTBs) and M
It has emerged that the domestic battery industry, which received trillions of won in tax deductions in the United States last year, might need to pay nearly 200 billion won in additional taxes by 2026 due to the implementation of a global minimum tax. Battery companies are currently investing in th
Netflix Services Korea has begun an administrative lawsuit against Korea’s tax authorities over 78 billion won (US$57 million) in tax imposed on the OTT giant. Much attention is being paid to see how the Korean court will rule on the unfair practice of global platform companies such as Netflix not p
Big South Korean companies are exiting China one after another. Business uncertainties are being fueled by fiercer competition and declining profitability in the Chinese market coupled with the U.S. government’s checks on China and policy changes by Chinese government authorities.Lotte Chemical sold
Celltrion Group has successfully sold the Asia-Pacific (APAC) “Primary Care” business rights, which it acquired from multinational pharmaceutical company Takeda Pharmaceuticals (hereafter Takeda) in 2020, after three years.On Jan. 18, Celltrion concluded a contract with Dong-A Pharmaceutical for the
JW Pharmaceutical announced on Jan. 15 that it has received approval from the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for a phase 3 clinical trial plan, or investigational new drug (IND), of its gout treatment drug Epaminurad (code name URC102).The Phase 3 clinical trial for Epami
MedPacto announced on Jan. 2 that it has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application for the combination therapy of Vactosertib and Pembrolizumab (commercially known as Keytruda).This clinical trial targets patients with previo
Celltrion Group revealed on Jan. 2 that it plans to divest the business rights, excluding domestic specialty pharmaceuticals, of the Primary Care sector in the Asia-Pacific region that it acquired from multinational pharmaceutical company Takeda Pharmaceutical in 2020. This split sale, which exclude
The National Tax Service (NTS) announced on Dec. 28 that it has collected 1.35 trillion won (US$1.05 billion) in tax assessments in the area of overseas tax evasion alone through tax investigations conducted this year. The figure exceeds the average annual collection for the three years before the C
A South Korea-based brokerage firm has been fined billions of won for allegedly allowing global investment banks (IBs) to short sell stocks without borrowing, ratcheting up tension in the Korean securities industry. This is because although the sanctions were imposed on the foreign-affiliated securi
Samsung C&T is joining hands with multinational corporations to participate in Oman’s large-scale green ammonia project.On Dec. 13, the construction division of Samsung C&T announced that it has formed a consortium with Japan’s Marubeni, Oman’s state-owned energy company OQ, and UAE’s Dutco, among o
WASHINGTON—In advanced industries such as computers and electronics, motor vehicles, and machinery and equipment, South Korea’s economy is 77 percent stronger than the relative global average, ranking second behind only Taiwan, according to a new report from the Information Technology and Innovation
Celltrion announced on Nov. 30 (local time) that it has completed the application for product licensing with the U.S. Food and Drug Administration (FDA) for its biosimilar CT-P41 of the osteoporosis medication Prolia-Xgeva (active ingredient: denosumab).Based on the results of global Phase 3 clinica
Chong Kun Dang announced on Nov. 6 that it has entered into a technology export agreement with Novartis worth US$1.305 billion for its new drug candidate CKD-510.Under the agreement, Novartis obtains exclusive rights outside of South Korea for the development and commercialization of CKD-510, a low-
While the government has been emphasizing price stability in recent times, foreign and multinational companies are exacerbating domestic price increases.According to the retail industry on Oct. 28, it has been pointed out that despite the government’s recent call for restraint in price increases, so
Samsung Electronics has decided to transition to a 200-layer NAND process at its NAND flash factory in Xi’an, China. The move to produce 236-layer products, which belong to the 8th generation of NAND, is seen as a strategic step to overcome a decline in performance due to sluggish global NAND demand
AprilBio revealed on Oct. 5 that they have obtained a U.S. patent for their candidate drug for autoimmune disease treatment, known as “APB-A1” (development code name, partner company Lundbeck code name Lu-AG22515).In October 2021, APB-A1 was exported to Lundbeck, a multinational pharmaceutical compa
On Sept. 20, President Yoon Suk-yeol proposed the formation of a “Carbon Free Alliance” to the international community during the United Nations General Assembly held in New York. This proposal includes bringing forward Carbon-Free Energy (CFE), which encompasses nuclear power and hydrogen energy, a
The large-scale imports of Chinese-made vehicles and batteries is expected to have a significant impact on the domestic car market and parts industry in Korea. The increase in Chinese imports can be attributed to competitive pricing, driven in part by rising raw material costs.Experts argue that whi
On March 10, 2013, KT entered into a Memorandum of Understanding (MOU) with the Rwandan government to establish a joint venture aimed at constructing an ultra-high-speed wireless network based on 4G LTE technology.According to industry sources on Sept. 4, KT recently filed a lawsuit against the Rwan